Thank you for visiting the homepage for Seattle's HIV Prevention Trials Unit at the University of Washington, a partner in the global HIV Prevention Trials Network. HPTU, along with our sister site, the Fred Hutchinson Cancer Research Center's HIV Vaccine Trials Unit (HVTU), is dedicated to testing the safety and efficacy of vaccines and other interventions designed to help reduce the transmission of HIV. We want to thank the over 1,000 people from the Puget Sound region who have volunteered their time and energy to help us with our mission. For more information about Seattle HPTU and our research, please explore the links on the left.

Recent article in The Lancet by Connie Celum Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial Click here to read the Summary

Sitemap

 
University of Washington/Seattle HPTU Site
Cabrini Medical Tower, 901 Boren Avenue
Suite 1300, Seattle, WA 98104
Campus mail: Box 359927
Fax: 206.520.3801
Tel: 206.520.3800